Certara, Inc.CERT
Price as of · delayed, not real-time
A provider of biosimulation software and technology-enabled services, Certara helps drug developers use model-informed drug development to reduce the time and cost of bringing therapies to market. The company's platforms, including Phoenix and Simcyp, are used by many of the top pharmaceutical firms and regulatory agencies, making it a key player in the clinical research technology space. Investors track Certara for its recurring subscription revenue and its exposure to the growing demand for digital tools in drug development.
Congressional Interest in Certara, Inc. (CERT)
No congressional trades have been disclosed for Certara, Inc. (CERT) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading CERT?
No congressional trades found for this stock.